References
- Short NJ, Rytting ME, Cortes JE. Acute myeloid leukaemia. Lancet. 2018;392(10147):593–606. doi:10.1016/S0140-6736(18)31041-9
- Del Principe MI, Buccisano F, Soddu S, et al., editors. Involvement of Central nervous system in adult patients with acute myeloid leukemia: incidence and impact on outcome. Seminars in hematology. 2018;55(4):209–214. doi:10.1053/j.seminhematol.2018.02.006
- Rozovski U, Ohanian M, Ravandi F, et al. Incidence of and risk factors for involvement of the Central nervous system in acute myeloid leukemia. Leuk Lymphoma. 2015;56(5):1392–1397. doi:10.3109/10428194.2014.953148
- Ganzel C, Lee J-W, Fernandez HF, et al. CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials. Blood Adv. 2021;5(22):4560–4568. doi:10.1182/bloodadvances.2021004999
- Cheng C-L, Li C-C, Hou H-A, et al. Risk factors and clinical outcomes of acute myeloid leukaemia with Central nervous system involvement in adults. BMC Cancer. 2015;15(1):344. doi:10.1186/s12885-015-1376-9
- Shihadeh F, Reed V, Faderl S, et al. Cytogenetic profile of patients with acute myeloid leukemia and Central nervous system disease. Cancer. 2012;118(1):112–117. doi:10.1002/cncr.26253
- Castagnola C, Nozza A, Corso A, et al. The value of combination therapy in adult acute myeloid leukemia with Central nervous system involvement. Haematologica. 1997;82(5):577–580.
- Dhakal P, Shostrom V, Al-Kadhimi ZS, et al. Usefulness of charlson comorbidity index to predict early mortality and overall survival in older patients with acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2020;20(12):804–812. e8. doi:10.1016/j.clml.2020.07.002
- Döhner H, Wei AH, Appelbaum FR, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140(12):1345–1377. doi:10.1182/blood.2022016867
- Alakel N, Stölzel F, Mohr B, et al. Symptomatic Central nervous system involvement in adult patients with acute myeloid leukemia. Cancer Manag Res. 2017;9:97–102. doi:10.2147/CMAR.S125259
- Paul S, Short NJ. Central nervous system involvement in adults with acute leukemia: diagnosis, prevention, and management. Curr Oncol Rep. 2022;24(4):427–436. doi:10.1007/s11912-022-01220-4
- Crespo-Solis E, López-Karpovitch X, Higuera J, et al. Diagnosis of acute leukemia in cerebrospinal fluid (CSF-acute leukemia). Curr Oncol Rep. 2012;14(5):369–378. doi:10.1007/s11912-012-0248-6
- Siegal T, Benouaich-Amiel A, Bairey O. Neurologic complications of acute myeloid leukemia. Diagnostic approach and therapeutic modalities. Blood Rev. 2022;53:100910. doi:10.1016/j.blre.2021.100910
- Acute Myeloid Leukemia Version 3. 2023. https://www.nccn.org/professionals/physician_gls/pdf/aml.pdf